BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31772111)

  • 1. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.
    Winship AL; Willson C; Hansen KR; Hutt KJ; Hickey M
    BMJ Open; 2019 Nov; 9(11):e033810. PubMed ID: 31772111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian Aging in Women With BRCA Germline Mutations.
    Lin W; Titus S; Moy F; Ginsburg ES; Oktay K
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3839-3847. PubMed ID: 28938488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
    Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
    Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 germline mutations may be associated with reduced ovarian reserve.
    Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY
    Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ovarian reserve and reproductive outcomes in
    Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M
    Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
    Merlino L; Chiné A; Galli C; Piccioni MG
    Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
    Turan V; Oktay K
    Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
    J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
    Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN
    Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.
    Denis-Laroque L; Drouet Y; Plotton I; Chopin N; Bonadona V; Lornage J; Salle B; Lasset C; Rousset-Jablonski C
    Breast; 2021 Oct; 59():239-247. PubMed ID: 34304065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status.
    C E DK; C VTT; J C EM; G W M LE; Irene H; Mariette G; J T VGR; Willem V; D LK; J M BF; M E BA
    Reprod Sci; 2023 Jan; 30(1):270-282. PubMed ID: 35705781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
    van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
    Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
    Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
    Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential implications on female fertility and reproductive lifespan in BRCA germline mutation women.
    de la Noval BD
    Arch Gynecol Obstet; 2016 Nov; 294(5):1099-1103. PubMed ID: 27561295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
    Giordano S; Garrett-Mayer E; Mittal N; Smith K; Shulman L; Passaglia C; Gradishar W; Pavone ME
    J Adolesc Young Adult Oncol; 2016 Dec; 5(4):337-343. PubMed ID: 27513691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimüllerian hormone levels are lower in BRCA2 mutation carriers.
    Johnson L; Sammel MD; Domchek S; Schanne A; Prewitt M; Gracia C
    Fertil Steril; 2017 May; 107(5):1256-1265.e6. PubMed ID: 28476184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.